Open AccessMetastasectomy in patients with non-resectable metastatic colorectal cancer receiving chemotherapy and anti-EGFR antibodies: a prospective, non-randomized, multicenter, phase II study
Author(s) -
Mikhail Fedyanin,
L. Yu. Vladimirova,
Natalya A Abramova,
Anna E. Storozhakova,
Irina L. Popova,
N. M. Tikhanovskaya,
Elena A. Kalabanova,
Ekaterina Panina,
А. И. Арзамасцева,
Е. Г. Рыбаков,
Л. В. Болотина,
Т. В. Устинова,
А. А. Качмазов,
Ilya Pokataev,
Alexey Tryakin,
O. Sekhina,
D. Chekini,
Х. Х.-М. Эльснукаева,
Д. В. Подлужный,
Sergei Tjulandin,
Oleg I. Kit
Publication year - 2019
Publication title -
onkologičeskaâ koloproktologiâ
Language(s) - English
Resource type - Journals
eISSN - 2413-0583
pISSN - 2220-3478
DOI - 10.17650/2220-3478-2019-9-1-65-72
Subject(s) - metastasectomy , medicine , colorectal cancer , tolerability , clinical endpoint , confidence interval , metastasis , prospective cohort study , chemotherapy , oncology , surgery , population , cancer , randomized controlled trial , gastroenterology , adverse effect , environmental health